These ROS/ cell-cycle patterns are lost in AML and MDS-RAEB with an aberrant ki67lowBCL2high phenotype observed in both CD34+ and CD34− blast subpopulations at disease presentation. The gene discussed is CD34; the disease is myelodysplastic syndrome.